Acumen Pharmaceuticals (ABOS) Liabilities and Shareholders Equity (2020 - 2026)
Acumen Pharmaceuticals (ABOS) reported Liabilities and Shareholders Equity of $116.01 million for Q2 2026, down 32.5% from $171.9 million a year earlier and down 13.2% from the prior quarter.
Powered by 
Analysis
Acumen Pharmaceuticals (ABOS) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends
At the end of FY2025, Acumen Pharmaceuticals posted Liabilities and Shareholders Equity of $122.83 million, down 48.6% from FY2024.
- Liabilities and Shareholders Equity has a five-year compound annual growth rate of 22.6% (FY2020 to FY2025).
- By year, Liabilities and Shareholders Equity came in at $238.99 million in FY2024 (-22.9%), $310.13 million in FY2023 (+57.8%), $196.59 million in FY2022 (-14.6%) and $230.33 million in FY2021 (+418.4%).
- The Q2 2026 figure ranks as the lowest quarterly Liabilities and Shareholders Equity since Q2 2021.
- Year over year, Liabilities and Shareholders Equity has now declined in each of the last eight quarters, with an average decline of 33.1% over the last eight quarters.
- The high point for year-over-year Liabilities and Shareholders Equity in five years was Q4 2021 (growth of 418.4%); the low point was Q4 2025 (a decline of 48.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $133.63 million (Q1 2026), $122.83 million (Q4 2025) and $142.22 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Acumen Pharmaceuticals | 147.03 Mn | -335.04 Mn | - | 116.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 116.01 Mn |
| Mar 31, 2026 | 133.63 Mn |
| Dec 31, 2025 | 122.83 Mn |
| Sep 30, 2025 | 142.22 Mn |
| Jun 30, 2025 | 171.90 Mn |
| Mar 31, 2025 | 204.48 Mn |
| Dec 31, 2024 | 238.99 Mn |
| Sep 30, 2024 | 266.98 Mn |
| Jun 30, 2024 | 288.91 Mn |
| Mar 31, 2024 | 300.97 Mn |
| Dec 31, 2023 | 310.13 Mn |
| Sep 30, 2023 | 286.37 Mn |
| Jun 30, 2023 | 177.41 Mn |
| Mar 31, 2023 | 187.86 Mn |
| Dec 31, 2022 | 196.59 Mn |
| Sep 30, 2022 | 203.26 Mn |
| Jun 30, 2022 | 211.68 Mn |
| Mar 31, 2022 | 220.09 Mn |
| Dec 31, 2021 | 230.33 Mn |
| Sep 30, 2021 | 234.85 Mn |
API Access
Acumen Pharmaceuticals Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ABOS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "ABOS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ABOS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();